Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
70
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER/PLENUM PUBLISHERS
Autores
HOAGLAND, Brenda
BONI, Raquel B. De
MOREIRA, Ronaldo I.
MADRUGA, Jose Valdez
GOULART, Silvia Pereira
TORRES, Thiago S.
LUZ, Paula M.
FERNANDES, Nilo Martinez
Citação
AIDS AND BEHAVIOR, v.21, n.5, p.1278-1287, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Antiretroviral pre-exposure prophylaxis (PrEP) is recommended to prevent HIV infection among high-risk men who have sex with men (MSM) though not available in Brazil where the HIV epidemic persists unabated in this group. This cross-sectional study describes PrEP awareness and willingness and associated factors among MSM and transvestite/transgender women (trans women) pre-screened for the PrEP Brasil study. Awareness was reported by 61.3 % of the participants and was associated with age, education, site, study period and prior HIV testing. Most participants (82.1 %) were willing to use PrEP, which was associated with site, study period, number of male condomless anal sexual partners and anal sex with HIV positive/unknown partners. PrEP information is need among young and less educated individuals. Willingness to use PrEP was high and future studies should be conducted to confirm PrEP acceptability and the characteristics of the population who chose to adopt this intervention.
Palavras-chave
Pre-exposure prophylaxis, HIV prevention, MSM, Transvestite, Transgender women, Awareness, Willingness
Referências
  1. Aghaizu A, 2013, SEX TRANSM INFECT, V89, P207, DOI 10.1136/sextrans-2012-050648
  2. Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524
  3. Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8
  4. Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173
  5. Bassichetto KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001423
  6. Bavinton BR, 2015, VIRAL LOAD AWARENESS, P141
  7. Bil JP, 2015, AIDS, V29, P955, DOI 10.1097/QAD.0000000000000639
  8. Blumenthal J, 2015, AIDS BEHAV, V19, P802, DOI 10.1007/s10461-015-0996-z
  9. Brandelli A, 2015, ARCH SEX BEHAV, V44, P521
  10. Brooks RA, 2012, AIDS PATIENT CARE ST, V26, P87, DOI 10.1089/apc.2011.0283
  11. Calabrese SK, 2015, AM J PUBLIC HEALTH, V105, P1960, DOI 10.2105/AJPH.2015.302816
  12. Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7
  13. Cohen SE, 2015, JAIDS-J ACQ IMM DEF, V68, P439, DOI 10.1097/QAI.0000000000000479
  14. De Boni R, 2014, CURR OPIN HIV AIDS, V9, P192, DOI 10.1097/COH.0000000000000031
  15. Departamento de DST Aids e Hepatites Virais, 2015, B EPI DEMIOLOGICO AI
  16. Deutsch MB, 2015, LANCET HIV, V2, pE512, DOI 10.1016/S2352-3018(15)00206-4
  17. Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238
  18. Escudero DJ, 2015, AIDS CARE, V27, P637, DOI 10.1080/09540121.2014.986051
  19. Golub SA, 2014, AIDS BEHAV, V18, P1686, DOI 10.1007/s10461-014-0770-7
  20. Grant RM, 2016, CURR OPIN HIV AIDS, V11, P3, DOI 10.1097/COH.0000000000000216
  21. Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3
  22. Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205
  23. Grinsztejn B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059768
  24. Hojilla JC, 2016, AIDS BEHAV, V20, P1461, DOI 10.1007/s10461-015-1055-5
  25. Holt M, 2012, SEX TRANSM INFECT, V88, P258, DOI 10.1136/sextrans-2011-050312
  26. Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504
  27. Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119
  28. Kurtz SP, 2016, LGBT HEALTH, DOI [10.1089/lgbt.2015.0069, DOI 10.1089/LGBT.2015.0069.]
  29. Lebouche B, 2016, HIV MED, V17, P152, DOI 10.1111/hiv.12286
  30. Liu A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001613
  31. Martins TA, 2013, AIDS CARE, V25, P606, DOI 10.1080/09540121.2012.726342
  32. Mascena MADS, 2015, AIDS BEHAV, V19, P1589
  33. McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2
  34. Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27
  35. Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273
  36. Mugwanya KK, 2013, LANCET INFECT DIS, V13, P1021, DOI 10.1016/S1473-3099(13)70226-3
  37. Saude M, 2013, PROTOCOLO CLIN DIRET
  38. Silva DS, 2015, AIDS BEHAV, DOI [10.1007/s10461-015-1235-3, DOI 10.1007/S10461-015-1235-3.]
  39. Sineath R Craig, 2013, J Int Assoc Provid AIDS Care, V12, P227, DOI 10.1177/2325957413488184
  40. Smith DK, 2015, SEX TRANSM DIS, V42, P88, DOI 10.1097/OLQ.0000000000000238
  41. Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711
  42. Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b
  43. Wheelock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054288
  44. Yang DZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059020
  45. Young I, 2014, REV RES ACCEPTABILIT, P195
  46. Zhou F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032329